2019 Request for Proposals
Submission Deadline: October 16, 2019
Applications can be submitted in response to this RFA until 5:00PM on October 16, 2019. Applicants will be notified of the funding decision by December 1, 2019, and funded applicants will have a period of 8 months from the notice of award (until July 31, 2020) to complete their projects.
A letter of intent must be submitted to email@example.com by October 1, 2019, to allow recruitment of external reviewers with subject matter expertise in the proposed area of inquiry.
The Consortium for Medical Marijuana Clinical Outcomes Research is comprised of public and private university member institutions within Florida. The Consortium provides awards to support clinical and translational research related to medical marijuana to investigators within member institutions.
The Consortium is charged by Florida statute to conduct and support research that will contribute to the body of scientific knowledge on the effects of the medical use of marijuana to inform policy and clinical practice related to the treatment of debilitating medical conditions with marijuana.
This award mechanism will consider fully developed research studies that generate novel evidence, as well as studies intended to facilitate the collection and/or analysis of preliminary data that will support future extramural funding applications.
|RFA Announcement||September 16, 2019|
|Letter of Intent Due||October 1, 2019|
|Application Deadline||October 16, 2019|
|Notice of Awards||December 1, 2019|
|Award Funding Period||December 1, 2019 through July 31, 2020|
All applicant principal investigators (PIs) must be faculty members of Consortium member institutions, which currently include: